|RFx ID :||24255097|
|Tender Name :||Future Procurement Opportunity (FPO) – Supply of Surgical implants, instrumentation and associated consumables|
|Reference # :|
|Open Date :||Q2 2021|
|Indicative RFx Release Date :||Q4 2021 [?]|
|Tender Type :||Future Procurement Opportunity (FPO)|
|Project Status :||Initial development [?]|
|Indicative Total Value :||$10M - $25M [?]|
|Tender Coverage :||Sole Agency [?]|
|Required Pre-qualifications :||None|
PHARMAC is planning on issuing a request for proposals for supply of surgical implants, medical and surgical instrumentation and associated consumables, not previously captured in a PHARMAC process, or currently listed on the Pharmaceutical Schedule.
The process is expected to include:
• Neurosurgical implants
• Occular implants
• Orthopaedic soft tissue implants
• Otolaryngology implants including but not limited to:
- Cochlear implants
- Stapes prostheses/middle ear implants
• Reconstruction implants including but not limited to:
- Breast implants
- Urological implants
- Implantable stimulators
- Synthetic and biological tissue implants and grafts
- Voice prosthesis
• Reusable instruments - excluding any currently proposed for consideration, or currently listed on the Pharmaceutical Schedule.
• Surgical Power tools
Excluded from scope is:
• Cardiovascular implants
The approximate gross annual expenditure of this category is likely to be in the range of $10million - $25million depending on final scope.
PHARMAC is working towards applying the full PHARMAC model to medical devices. Ultimately, PHARMAC will make choices about which new medical devices will be introduced for use in DHB Hospitals, that will get the best health outcomes from within a set amount of funding. This potential procurement opportunity is being scoped as a medical device category area that may not have been captured through other national contracting procurement processes.
For further information on PHARMAC’s approach to medical devices please see the PHARMAC website: https://www.pharmac.govt.nz/hospital-devices/.
Any listing agreements resulting from this process following evaluation, negotiation, consultation and approval, will be non-exclusive and DHBs will continue to choose which medical devices they use from any PHARMAC agreement.